Cargando…

Comparative study of the effect of rivaroxaban and fondaparinux on monocyte’s coagulant activity and cytokine release

OBJECTIVES: Tissue factor (TF) exposed on activated monocytes and macrophages is involved in thrombosis through activation of factor X and cytokine release, responsible for inflammation and thrombosis. We investigated the effect of two anti-factor Xa drugs: rivaroxaban, a direct anti-Xa inhibitor, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laurent, Marc, Joimel, Ulrich, Varin, Rémi, Cazin, Lionel, Gest, Caroline, Le-Cam-Duchez, Veronique, Jin, Jian, Liu, Jielin, Vannier, Jean-Pierre, Lu, He, Soria, Jeannette, Li, Hong, Soria, Claudine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298120/ https://www.ncbi.nlm.nih.gov/pubmed/25601900 http://dx.doi.org/10.1186/2162-3619-3-30

Ejemplares similares

Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate
por: Joimel, Ulrich, et al.
Publicado: (2010)

Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines
por: Gest, Caroline, et al.
Publicado: (2013)

Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy
por: Huang, Limin, et al.
Publicado: (2013)

Fibrinogen αC domain: Its importance in physiopathology
por: Soria, Jeannette, et al.
Publicado: (2019)

New Combinational Assay Using Soluble Fibrin and D-Dimer Determinations: A Promising Strategy for Identifying Patients with Suspected Venous Thromboembolism
por: Mirshahi, Shahsoltan, et al.
Publicado: (2014)

The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018)

Hemorrhagic disseminated intravascular coagulation after (177)Lu-Dotatate in metastatic midgut neuroendocrine tumor: A case report
por: Worbe, Noémie, et al.
Publicado: (2021)

Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)

Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness
por: Blot, E, et al.
Publicado: (2003)

When Will Fondaparinux Induce Thrombocytopenia?
por: Chen, Li-Yu, et al.
Publicado: (2022)

Design and Synthesis of Neutralizable Fondaparinux
por: Zhang, Liangwei, et al.
Publicado: (2022)

Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation
por: Burghaus, Rolf, et al.
Publicado: (2011)

Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells
por: Hu, Chaoquan, et al.
Publicado: (2012)

Management of acute coronary syndromes with fondaparinux
por: Wienbergen, Harm, et al.
Publicado: (2007)

Thromboelastographic monitoring of fondaparinux in surgical patients
por: Martinez, B, et al.
Publicado: (2013)

Routine coagulation test abnormalities caused by rivaroxaban: A case report
por: Song, Zikai, et al.
Publicado: (2018)

Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation
por: Kim, Paul Y., et al.
Publicado: (2018)

Treatment with rivaroxaban and monitoring of coagulation profiles in two dogs with venous thromboembolism
por: UCHIDA, Mona, et al.
Publicado: (2020)

Association between hypocalcemia and rivaroxaban in coagulation disorders: a case report
por: Pos, Alexandre Mio, et al.
Publicado: (2020)

Investigation of Coagulation Biomarkers to Assess Clinical Deterioration in SARS-CoV-2 Infection
por: Billoir, Paul, et al.
Publicado: (2021)

Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020)

Probable fondaparinux-associated bullous hemorrhagic dermatosis
por: Lovatt, Catherine Anne, et al.
Publicado: (2021)

New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects
por: Denoyelle, C, et al.
Publicado: (2003)

Considerations for routine coagulation monitoring with rivaroxaban: A case report and review of the literature
por: Wu, Hai-Di, et al.
Publicado: (2019)

Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests
por: Cho, Han-Jin, et al.
Publicado: (2020)

Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
por: Yin, Lu, et al.
Publicado: (2022)

Fondaparinux: Should It Be Studied in Patients with COVID-19 Disease?
por: Marongiu, Francesco, et al.
Publicado: (2020)

Fondaparinux and bleeding risk in COVID-19: unsolved question
por: Russo, Vincenzo, et al.
Publicado: (2021)

Dermatose bulleuse hémorragique probablement associée au fondaparinux
por: Lovatt, Catherine Anne, et al.
Publicado: (2021)

Fondaparinux: A cornerstone drug in acute coronary syndromes
por: Khan, Mohammed Yunus, et al.
Publicado: (2022)

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
por: Shimizu, Kazuhiro, et al.
Publicado: (2018)

Effects of Rivaroxaban on Platelet Activation and Platelet–Coagulation Pathway Interaction: In Vitro and In Vivo Studies
por: Perzborn, Elisabeth, et al.
Publicado: (2015)

Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations
por: Kaserer, Alexander, et al.
Publicado: (2019)

Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib
por: Huang, Limin, et al.
Publicado: (2014)

Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells
por: HUANG, LIMIN, et al.
Publicado: (2015)

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction
por: Turpie, Alexander GG
Publicado: (2006)

Fondaparinux–Associated Rectus Sheath Hematoma: Skating on Thin Ice
por: Sabanis, Nikolaos, et al.
Publicado: (2020)

The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome
por: Sayar, Zara, et al.
Publicado: (2022)

Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma
por: Tijeras-Raballand, Annemilaï, et al.
Publicado: (2010)

Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials
por: Scheres, Luuk J. J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mfun6k9qi247jkdufj4n24jd5p